Pasar al contenido principal

NUEVO BIOMATERIAL BIO-ACTIVO PARA LA REGENERACION DE LESIONES MEDULARES

RTI2018-095872-B-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRÍNCIPE FELIPE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Regenerative and resorbable PLA/HA hybrid construct for tendon/ligament tissue engineering

  • Araque-Monrós, M. C.
  • García-Cruz, D. M.
  • Escobar-Ivirico, J. L.
  • Gil-Santos, L.
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
  • Más Estellés, Jorge|||0000-0001-8446-6737
[EN] Tendon and ligament shows extremely limited endogenous regenerative capacity. Current treatments are based on the replacement and or augmentation of the injured tissue but the repaired tissue rarely achieve functionality equal to that of the preinjured tissue. To address this challenge, tissue engineering has emerged as a promising strategy. This study develops a regenerative and resorbable hybrid construct for tendon and ligament engineering. The construct is made up by a hollow poly-lactic acid braid with embedded microspheres carrying cells and an anti-adherent coating, with all the parts being made of biodegradable materials. This assembly intends to regenerate the tissue starting from the interior of the construct towards outside while it degrades. Fibroblasts cultured on poly lactic acid and hyaluronic acid microspheres for 6 h were injected into the hollow braid and the construct was cultured for 14 days. The cells thus transported into the lumen of the construct were able to migrate and adhere to the braid fibers naturally, leading to a homogeneous proliferation inside the braid. Moreover, no cells were found on the outer surface of the coating. Altogether, this study demonstrated that PLA/HA hybrid construct could be a promising material for tendon and ligament repair., This work was supported by AITEX (Textil Research Institute, Alcoi, Alicante, Spain) through the researching contract "Development of braided biomaterials for biomedical applications'' and also funded by AEI "RTI2018-095872-B-C21 and C22/ERDF''.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A rationally designed self-immolative linker enhances the synergism between a polymer-rock inhibitor conjugate and neural progenitor cells in the treatment of spinal cord injury

  • Giraldo, Esther|||0000-0001-5488-3011
  • Nebot, V. J.
  • Dordevic, S.
  • Requejo-Aguilar, R.
  • Alastrue-Agudo, A.
  • Zagorodko, O.
  • Armiñán, A.
  • Martinez-Rojas, B.
  • Vicent, M.J.
  • Moreno Manzano, V.
[EN] Rho/ROCK signaling induced after spinal cord injury (SCI) contributes to secondary damage by promoting apoptosis, inflammation, and axon growth inhibition. The specific Rho-kinase inhibitor fasudil can contribute to functional regeneration after SCI, although inherent low stability has hampered its use. To improve the therapeutic potential of fasudil, we now describe a family of rationally-designed bioresponsive polymer-fasudil conjugates based on an understanding of the conditions after SCI, such as low pH, enhanced expression of specific proteases, and a reductive environment. Fasudil conjugated to poly-l-glutamate via a self-immolative redox-sensitive linker (PGA-SS-F) displays optimal release kinetics and, consequently, treatment with PGA-SS-F significantly induces neurite elongation and axon growth in dorsal root ganglia explants, spinal cord organotypic cultures, and neural precursor cells (NPCs). The intrathecal administration of PGA-SS-F after SCI in a rat model prevents early apoptosis and induces the expression of axonal growth- and neuroplasticity-associated markers to a higher extent than the free form of fasudil. Moreover, a combination treatment comprising the acute transplantation of NPCs pre-treated with PGA-SS-F leads to enhanced cell engraftment and reduced cyst formation after SCI. In chronic SCI, combinatory treatment increases the preservation of neuronal fibers. Overall, this synergistic combinatorial strategy may represent a potentially efficient clinical approach to SCI treatment., This research was funded by FEDER/Ministerio de Ciencia e Innovacion -Agencia Estatal de Investigacion [RTI2018-095872-B-C21/ERDF], Ministerio de Ciencia e Innovacion [SAF2016-80427-R, PID2019-108806RB-I00], Fundacio Marato TV3 [20172230, 20172231 and 20172110] Fundacion Step by Step, Agencia Valenciana de Innovacion (AVI) [INNVAL10/19/047] and MINECO/FEDER, UE; Fondo Europeo de Desarrollo Regional (FEDER) incluido en el Programa Operativo FEDER de la Comunidad Valenciana 2014-2020.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Hyaluronic Acid Demilune Scaffold and Polypyrrole-Coated Fibers Carrying Embedded Human Neural Precursor Cells and Curcumin for Surface Capping of Spinal Cord Injuries

  • Elkhenany, Hoda
  • Bonilla, Pablo
  • Alastrue Agudo, Ana
  • Edel, Michael J.
  • Vicent, María Jesus
  • Rodriguez Doblado, Laura
  • Moreno Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
  • Gisbert-Roca, Fernando|||0000-0003-3937-5822
  • Martínez-Ramos, Cristina|||0000-0002-6540-4714
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
[EN] Tissue engineering, including cell transplantation and the application of biomaterials and bioactive molecules, represents a promising approach for regeneration following spinal cord injury (SCI). We designed a combinatorial tissue-engineered approach for the minimally invasive treatment of SCI¿a hyaluronic acid (HA)-based scaffold containing polypyrrole-coated fibers (PPY) combined with the RAD16-I self-assembling peptide hydrogel (Corning® PuraMatrix¿peptide hydrogel (PM)), human induced neural progenitor cells (iNPCs), and a nanoconjugated form of curcumin (CURC). In vitro cultures demonstrated that PM preserves iNPC viability and the addition of CURC reduces apoptosis and enhances the outgrowth of Nestin-positive neurites from iNPCs, compared to nonembedded iNPCs. The treatment of spinal cord organotypic cultures also demonstrated that CURC enhances cell migration and prompts a neuron-like morphology of embedded iNPCs implanted over the tissue slices. Following sub-acute SCI by traumatic contusion in rats, the implantation of PMembedded iNPCs and CURC with PPY fibers supported a significant increase in neuro-preservation (as measured by greater III-tubulin staining of neuronal fibers) and decrease in the injured area (as measured by the lack of GFAP staining). This combination therapy also restricted platelet-derived growth factor expression, indicating a reduction in fibrotic pericyte invasion. Overall, these findings support PM-embedded iNPCs with CURC placed within an HA demilune scaffold containing PPY fibers as a minimally invasive combination-based alternative to cell transplantation alone., This research was funded by the Science by Women program, Women for Africa Foundation to H.E. and the grants FEDER/Ministerio de Ciencia e Innovacion-Agencia Estatal de Investigacion [RTI2018-095872-B-C21 and -C22/ERDF]; Part of the equipment employed in this work was funded by Generalitat Valenciana and cofinanced with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020). RISEUP project FetOpen in H2020 Program: H2020-FETOPEN-2018-2019-2020-01.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

NPC transplantation rescues sci-driven cAMP/EPAC2 alterations, leading to neuroprotection and microglial modulation

  • Martinez-Rojas, Beatriz
  • Grillo-Risco, Rubén
  • Hidalgo, Marta R.
  • López-Mocholi, Eric
  • Alastrue-Agudo, Ana
  • Garcia-Garcia, Francisco
  • Moreno-Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
[EN] Neural progenitor cell (NPC) transplantation represents a promising treatment strategy for spinal cord injury (SCI); however, the underlying therapeutic mechanisms remain incompletely understood. We demonstrate that severe spinal contusion in adult rats causes transcriptional dysregulation, which persists from early subacute to chronic stages of SCI and afects nearly 20,000 genes in total tissue extracts. Functional analysis of this dysregulated transcriptome reveals the signifcant downregulation of cAMP signalling components immediately after SCI, involving genes such as EPAC2 (exchange protein directly activated by cAMP), PKA, BDNF, and CAMKK2. The ectopic transplantation of spinal cord-derived NPCs at acute or subacute stages of SCI induces a signifcant transcriptional impact in spinal tissue, as evidenced by the normalized expression of a large proportion of SCI-afected genes. The transcriptional modulation pattern driven by NPC transplantation includes the rescued expression of cAMP signalling genes, including EPAC2. We also explore how the sustained in vivo inhibition of EPAC2 downstream signalling via the intrathecal administration of ESI-05 for 1 week impacts therapeutic mechanisms involved in the NPC-mediated treatment of SCI. NPC transplantation in SCI rats in the presence and absence of ESI-05 administration prompts increased rostral cAMP levels; however, NPC and ESI-05 treated animals exhibit a signifcant reduction in EPAC2 mRNA levels compared to animals receiving only NPCs treatment. Compared with transplanted animals, NPCs+ESI-05 treatment increases the scar area (as shown by GFAP staining), polarizes microglia into an infammatory phenotype, and increases the magnitude of the gap between NeuN+cells across the lesion. Overall, our results indicate that the NPC-associated therapeutic mechanisms in the context of SCI involve the cAMP pathway, which reduces infammation and provides a more neuropermissive environment through an EPAC2-dependent mechanism., This research was funded by FEDER/Ministerio de Ciencia e Innovacion - Agencia Estatal de Investigacion [RTI2018-095872-B-C21/ERDF] and RISEUP EU grant (Ref. 964562) from FetOpen H2020 program. Part of the equipment employed in this work was funded by Generalitat Valenciana and cofinanced with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020) and the UE; Fondo Europeo de Desarrollo Regional (FEDER) incluido en el Programa Operativo FEDER de la Comunidad Valenciana 2014-2020. B. Martinez-Rojas was supported by a grant from the Conselleria de Educacion, Investigacion, Cultura y Deporte de la Generalitat Valenciana and the European Social Fundation ACIF/2019/120.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Strategy for Magnetic and Electric Stimulation to Enhance Proliferation and Differentiation of NPCs Seeded over PLA Electrospun Membranes

  • Cuenca-Ortolá, Irene
  • Martinez-Rojas, Beatriz
  • Moreno Manzano, Victoria
  • García Castelló, Marcos
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
  • Martínez-Ramos, Cristina|||0000-0002-6540-4714
  • Más Estellés, Jorge|||0000-0001-8446-6737
[EN] Neural progenitor cells (NPCs) have been shown to serve as an efficient therapeutic strategy in different cell therapy approaches, including spinal cord injury treatment. Despite the reported beneficial effects of NPC transplantation, the low survival and differentiation rates constrain important limitations. Herein, a new methodology has been developed to overcome both limitations by applying a combination of wireless electrical and magnetic stimulation to NPCs seeded on aligned poly(lactic acid) nanofibrous scaffolds for in vitro cell conditioning prior transplantation. Two stimulation patterns were tested and compared, continuous (long stimulus applied once a day) and intermittent (short stimulus applied three times a day). The results show that applied continuous stimulation promotes NPC proliferation and preferential differentiation into oligodendrocytic and neuronal lineages. A neural-like phenotypic induction was observed when compared to unstimulated NPCs. In contrast, intermittent stimulation patterns did not affect NPC proliferation and differentiation to oligodendrocytes or astrocytes morphology with a detrimental effect on neuronal differentiation. This study provides a new approach of using a combination of electric and magnetic stimulation to induce proliferation and further neuronal differentiation, which would improve therapy outcomes in disorders such as spinal cord injury., Grants RTI2018-095872-B-C21/ERDF and RTI2018-095872-B-C22/ERDF funded by MCIN/AEI//10.13039/501100011033 and by ERDF A way of making Europe. This project was also funded by Project 964562 H2020 FetOpen program. Irene Cuenca Ortola acknowledges the grant PRE2019-090716 funded by MCIN/AEI/10.13039/501100011033 and by ESF Investing in your future. B. Martinez Rojas was supported by a grant from the Conselleria de Educacion, Investigacion, Cultura y Deporte de la Generalitat Valenciana and the European Social Fundation ACIF/2019/120.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Transplantation of Human Fetal Spinal cord-derived NPCs Primed with a Polyglutamate-conjugated Rho/Rock Inhibitor as a Therapy for Acute Spinal Cord Injury

  • Giraldo, Esther|||0000-0001-5488-3011
  • Bonilla, Pablo
  • Mellado, Mara
  • García-Manau, Pablo
  • Rodó, Carlota
  • Alastrue, Ana
  • López, Eric
  • Carreras Moratonas, Elena
  • Pellisé, Ferran
  • Dordevic, Snezana
  • Vicent, María J.
  • Moreno Manzano, Victoria
[EN] Neural precursor cell (NPC) transplantation represents a promising therapy for treating spinal cord injuries (SCIs); however, despite successful results obtained in preclinical models, the clinical translation of this approach remains challenging due, in part, to the lack of consensus on an optimal cell source for human neuronal cells. Depending on the cell source, additional limitations to NPC-based therapies include high tumorigenic potential, alongside poor graft survival and engraftment into host spinal tissue. We previously demonstrated that NPCs derived from rat fetal spinal cords primed with a polyglutamate (PGA)-conjugated form of the Rho/Rock inhibitor fasudil (PGA-SS-FAS) displayed enhanced neuronal differentiation and graft survival when compared to non-primed NPCs. We now conducted a similar study of human-fetal-spinal-cord-derived NPCs (hfNPCs) from legal gestational interruptions at the late gestational stage, at 19-21.6 weeks. In vitro, expanded hfNPCs retained neural features, multipotency, and self-renewal, which supported the development of a cell banking strategy. Before transplantation, we established a simple procedure to prime hfNPCs by overnight incubation with PGA-SS-FAS (at 50 ¿M FAS equiv.), which improved neuronal differentiation and overcame neurite-like retraction after lysophosphatidic-acid-induced Rho/Rock activation. The transplantation of primed hfNPCs into immune-deficient mice (NU(NCr)-Foxn1nu) immediately after the eighth thoracic segment compression prompted enhanced migration of grafted cells from the dorsal to the ventral spinal cord, increased preservation of GABAergic inhibitory Lbx1-expressing and glutamatergic excitatory Tlx3-expressing somatosensory interneurons, and elevated the numbers of preserved, c-Fos-expressing, activated neurons surrounding the injury epicenter, all in a low percentage. Overall, the priming procedure using PGA-SS-FAS could represent an alternative methodology to improve the capabilities of the hfNPC lines for a translational approach for acute SCI treatment., This research was funded by Fundacio Marato TV3 2017/refs.20172230, 20172231, Agencia Valenciana de Innovacion (AVI) (INNVAL10/19/047 and Grants RTI2018-095872-B-C21 and PDI20211243590B-I00/ERDF funded by MCIN/AEI//10.13039/501100011033 and by ERDF A way of making Europe). This project was also funded by Project 964562 (RISEUP), H2020 FetOpen program.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Human-Induced Neural and Mesenchymal Stem Cell Therapy Combined with a Curcumin Nanoconjugate as a Spinal Cord Injury Treatment

  • Bonilla, Pablo
  • Hernandez, Joaquim
  • González-Pérez, Miguel A.
  • Alastrue-Agudo, Ana
  • Elkhenany, Hoda
  • Vicent, María J.
  • Edel, Michael
  • Moreno-Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
  • Navarro i García, Xavier
[EN] We currently lack effective treatments for the devastating loss of neural function associated with spinal cord injury (SCI). In this study, we evaluated a combination therapy comprising human neural stem cells derived from induced pluripotent stem cells (iPSC-NSC), human mesenchymal stem cells (MSC), and a pH-responsive polyacetal-curcumin nanoconjugate (PA-C) that allows the sustained release of curcumin. In vitro analysis demonstrated that PA-C treatment protected iPSC-NSC from oxidative damage in vitro, while MSC co-culture prevented lipopolysaccharide-induced activation of nuclear factor-kappa B (NF-kappa B) in iPSC-NSC. Then, we evaluated the combination of PA-C delivery into the intrathecal space in a rat model of contusive SCI with stem cell transplantation. While we failed to observe significant improvements in locomotor function (BBB scale) in treated animals, histological analysis revealed that PA-C-treated or PA-C and iPSC-NSC + MSC-treated animals displayed significantly smaller scars, while PA-C and iPSC-NSC + MSC treatment induced the preservation of beta-III Tubulin-positive axons. iPSC-NSC + MSC transplantation fostered the preservation of motoneurons and myelinated tracts, while PA-C treatment polarized microglia into an anti-inflammatory phenotype. Overall, the combination of stem cell transplantation and PA-C treatment confers higher neuroprotective effects compared to individual treatments., This research was funded by Fundacio Marato TV3 2017/refs.20172230, 20172231 and 20172110; FEDER/Ministerio de Ciencia e Innovacion-Agencia Estatal de Investigacion "RTI2018095872-B-C21/ERDF", Agencia Valenciana de Innovacion (AVI) INNVAL10/19/047 and TERCEL (RD12/0019/0011) funds from the Instituto de Salud Carlos III of Spain.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Optogenetic Modulation of Neural Progenitor Cells Improves Neuroregenerative Potential

  • Giraldo, Esther|||0000-0001-5488-3011
  • Palmero-Canton, David
  • Martínez-Rojas, Beatriz
  • Sanchez-Martin, Maria del Mar
  • Moreno-Manzano, Victoria
[EN] Neural progenitor cell (NPC) transplantation possesses enormous potential for the treatment of disorders and injuries of the central nervous system, including the replacement of lost cells or the repair of host neural circuity after spinal cord injury (SCI). Importantly, cell-based therapies in this context still require improvements such as increased cell survival and host circuit integration, and we propose the implementation of optogenetics as a solution. Blue-light stimulation of NPCs engineered to ectopically express the excitatory light-sensitive protein channelrhodopsin-2 (ChR2-NPCs) prompted an influx of cations and a subsequent increase in proliferation and differentiation into oligodendrocytes and neurons and the polarization of astrocytes from a pro-inflammatory phenotype to a pro-regenerative/anti-inflammatory phenotype. Moreover, neurons derived from blue-light-stimulated ChR2-NPCs exhibited both increased branching and axon length and improved axon growth in the presence of axonal inhibitory drugs such as lysophosphatidic acid or chondroitin sulfate proteoglycan. Our results highlight the enormous potential of optogenetically stimulated NPCs as a means to increase neuroregeneration and improve cell therapy outcomes for enhancing better engraftments and cell identity upon transplantation in conditions such as SCI., This research was funded by FEDER/Ministerio de Ciencia e Innovacion-Agencia Estatal de Investigacion "RTI2018-095872-B-C21/ERDF", Fundacio La Marato de TV3 2017/refs. 20172230, 20172231 and 20172110, Agencia Valenciana de Innovacion (AVI) INNVAL10/19/047, ACIF2019 and MINECO/FEDER, UE; Fondo Europeo de Desarrollo Regional (FEDER) included in the Programa Operativo FEDER de la Comunidad Valenciana 2014-2020.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Fetal rat neural progenitor cell transplantation after spinal cord injury improves motor recovery following optogenetic stimulation

  • Sanchez-Martin, Maria del Mar
  • Alastrue-Agudo, Ana
  • López-Mocholí, Eric
  • Martín-Pérez, Samuel
  • Maninno, Lois
  • Fraga Sánchez, Ana Isabel
  • Vidal-Beneyto, Quique
  • Conesa, Ana
  • van Niekerk, Erna
  • Tuszynski, Mark
  • Moreno-Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
  • Paniagua G
  • Monreal-Trigo, Javier|||0000-0002-4067-1867
  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
[EN] Spinal cord injury (SCI) disrupts communication between the brain and the spinal circuits, resulting in severe motor, sensory, and autonomic dysfunctions. Transplantation of neural progenitor cells (NPCs) has been demonstrated to provide multiple benefits; however, limited graft survival and neuronal differentiation must be overcome to achieve improved results. Here, we explore the optogenetic modulation of rat spinal cord-derived NPC expressing channelrhodopsin-2 (ChR2) through adeno-associated virus serotype 9-mediated transduction, transplanted into the sub-acute stage after SCI. Daily blue-light stimulation and ChR2-dependent activation control of the modified NPC significantly enhanced locomotor skills, run speed, sustained walking coordination, and body stability in a rat SCI model. Engrafted rat NPC-ChR2 reduces astrocytic reactivity and the injured area volume, preserves a higher number of descending propriospinal neurons above the injury and a higher innervation of 5-hydroxytryptamine fibers to choline acetyltransferase-positive motoneurons below the injury, and the increased vesicular glutamate transporter expression suggests an enhanced excitatory synaptic activity. Overall, sustained activation of rat NPC post-transplantation offers a promising strategy for improved locomotor recovery following SCI., The publication of the present research is funded and part of the projects PID2021-1243590B-I100 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU and RTI2018-095872-B-C21 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU, "Una manera de hacer Europa," and by the Generalitat Valenciana (GVA) PROMETEO grant CIPROM/2022/25 (to V.M.M) . The GVA also funded part of the equipment employed in this work and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020) and the UE; Fondo Europeo de Desarrollo Regional (FEDER) included in the Programa Operativo FEDER de la Comunidad Valenciana 2014-2020. The authors also thank Dr. Beatriz Martinez Rojas, Dr. Sonia Jai Hingorani, and Dr. Maria Pedraza for their scientific discussion and suggestions; Marta Llansona for her technical support in chromatographic measurements; and Stuart P. Atkinson for English editing.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chondroitin sulfate proteoglycans prevent immune cell phenotypic conversion and inflammation resolution via TLR4 in rodent models of spinal cord injury

  • Francos-Quijorna, Isaac
  • Sánchez-Petidier, Marina
  • Burnside, Emily R.
  • Badea, Smaranda R.
  • Torres-Espin, Abel
  • Marshall, Lucy
  • de Winter, Fred
  • Verhaagen, Joost
  • Moreno-Manzano, Victoria
  • Bradbury, Elizabeth J.
Chondroitin sulfate proteoglycans (CSPGs) act as potent inhibitors of axonal growth and neuroplasticity after spinal cord injury (SCI). Here we reveal that CSPGs also play a critical role in preventing inflammation resolution by blocking the conversion of pro-inflammatory immune cells to a pro-repair phenotype in rodent models of SCI. We demonstrate that enzymatic digestion of CSPG glycosaminoglycans enhances immune cell clearance and reduces pro-inflammatory protein and gene expression profiles at key resolution time points. Analysis of phenotypically distinct immune cell clusters revealed CSPG-mediated modulation of macrophage and microglial subtypes which, together with T lymphocyte infiltration and composition changes, suggests a role for CSPGs in modulating both innate and adaptive immune responses after SCI. Mechanistically, CSPG activation of a pro-inflammatory phenotype in pro-repair immune cells was found to be TLR4-dependent, identifying TLR4 signalling as a key driver of CSPG-mediated immune modulation. These findings establish CSPGs as critical mediators of inflammation resolution failure after SCI in rodents, which leads to prolonged inflammatory pathology and irreversible tissue destruction., The work was supported by grants from the following organisations: the U.K. Medical Research Council (SNCF G1002055; ERA-NET NEURON MR/R005532/1) and the Rosetrees Trust (CF1\100006) to E.J.B.; the Fondo Europeo de Desarrollo Regional (FEDER)/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación “RTI2018-095872-B-C21/ERDF” (included in the FEDER programme for the Comunidad Valenciana 2014-2020) to V.M.M.; and Wings for Life Spinal Cord Research Foundation (WFL-UK-01/20 Project 214 to E.J.B.; WFL-NL-25/20 Project 238 to J.V.). We thank Dr. S. Akira (Osaka) and Dr C. Guerri for providing TLR4−/− mice.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chondroitin sulfate proteoglycans prevent immune cell phenotypic conversion and inflammation resolution via TLR4 in rodent models of spinal cord injury

  • Francos-Quijorna, Isaac
  • Sánchez-Petidier, Marina
  • Burnside, Emily R.
  • Badea, Smaranda R.
  • Torres-Espin, Abel
  • Marshall, Lucy
  • de Winter, Fred
  • Verhaagen, Joost
  • Moreno-Manzano, Victoria
  • Bradbury, Elizabeth J.
Chondroitin sulfate proteoglycans (CSPGs) act as potent inhibitors of axonal growth and neuroplasticity after spinal cord injury (SCI). Here we reveal that CSPGs also play a critical role in preventing inflammation resolution by blocking the conversion of pro-inflammatory immune cells to a pro-repair phenotype in rodent models of SCI. We demonstrate that enzymatic digestion of CSPG glycosaminoglycans enhances immune cell clearance and reduces pro-inflammatory protein and gene expression profiles at key resolution time points. Analysis of phenotypically distinct immune cell clusters revealed CSPG-mediated modulation of macrophage and microglial subtypes which, together with T lymphocyte infiltration and composition changes, suggests a role for CSPGs in modulating both innate and adaptive immune responses after SCI. Mechanistically, CSPG activation of a pro-inflammatory phenotype in pro-repair immune cells was found to be TLR4-dependent, identifying TLR4 signalling as a key driver of CSPG-mediated immune modulation. These findings establish CSPGs as critical mediators of inflammation resolution failure after SCI in rodents, which leads to prolonged inflammatory pathology and irreversible tissue destruction., The work was supported by grants from the following organisations: the U.K. Medical Research Council (SNCF G1002055; ERA-NET NEURON MR/R005532/1) and the Rosetrees Trust (CF1\100006) to E.J.B.; the Fondo Europeo de Desarrollo Regional (FEDER)/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación “RTI2018-095872-B-C21/ERDF” (included in the FEDER programme for the Comunidad Valenciana 2014-2020) to V.M.M.; and Wings for Life Spinal Cord Research Foundation (WFL-UK-01/20 Project 214 to E.J.B.; WFL-NL-25/20 Project 238 to J.V.). We thank Dr. S. Akira (Osaka) and Dr C. Guerri for providing TLR4−/− mice.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fetal rat neural progenitor cell transplantation after spinal cord injury improves motor recovery following optogenetic stimulation

  • Sánchez-Martín, María del Mar
  • Giraldo, Esther
  • Vidal Beneyto, Quique
  • Conesa, Ana
  • Moreno-Manzano, Victoria
The authors declare no competing interests: et al., Spinal cord injury (SCI) disrupts communication between the brain and the spinal circuits, resulting in severe motor, sensory, and autonomic dysfunctions. Transplantation of neural progenitor cells (NPCs) has been demonstrated to provide multiple benefits; however, limited graft survival and neuronal differentiation must be overcome to achieve improved results. Here, we explore the optogenetic modulation of rat spinal cord-derived NPC expressing channelrhodopsin-2 (ChR2) through adeno-associated virus serotype 9-mediated transduction, transplanted into the sub-acute stage after SCI. Daily blue-light stimulation and ChR2-dependent activation control of the modified NPC significantly enhanced locomotor skills, run speed, sustained walking coordination, and body stability in a rat SCI model. Engrafted rat NPC-ChR2 reduces astrocytic reactivity and the injured area volume, preserves a higher number of descending propriospinal neurons above the injury and a higher innervation of 5-hydroxytryptamine fibers to choline acetyltransferase-positive motoneurons below the injury, and the increased vesicular glutamate transporter expression suggests an enhanced excitatory synaptic activity. Overall, sustained activation of rat NPC post-transplantation offers a promising strategy for improved locomotor recovery following SCI., The publication of the present research is funded and part of the projects PID2021-1243590B-I100 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU and RTI2018-095872-B-C21 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU, “Una manera de hacer Europa,” and by the Generalitat Valenciana (GVA) PROMETEO grant CIPROM/2022/25 (to V.M.M). The GVA also funded part of the equipment employed in this work and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020) and the UE; Fondo Europeo de Desarrollo Regional (FEDER) included in the Programa Operativo FEDER de la Comunidad Valenciana 2014–2020., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Human-induced neural and mesenchymal stem cell therapy combined with a curcumin nanoconjugate as a spinal cord injury treatment

  • Bonilla, Pablo
  • Hernández Martín, Joaquim|||0000-0003-1409-5568
  • Giraldo, Esther
  • González-Pérez, Miguel A.
  • Alastrue-Agudo, Ana|||0000-0002-9326-2119
  • Elkhenany, Hoda|||0000-0003-2638-8640
  • Vicent, María J.
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Edel, Michael J.|||0000-0002-5619-8680
  • Moreno-Manzano, Victoria|||0000-0002-6035-9491
We currently lack effective treatments for the devastating loss of neural function associated with spinal cord injury (SCI). In this study, we evaluated a combination therapy comprising human neural stem cells derived from induced pluripotent stem cells (iPSC-NSC), human mesen-chymal stem cells (MSC), and a pH-responsive polyacetal-curcumin nanoconjugate (PA-C) that al-lows the sustained release of curcumin. In vitro analysis demonstrated that PA-C treatment pro-tected iPSC-NSC from oxidative damage in vitro, while MSC co-culture prevented lipopolysaccha-ride-induced activation of nuclear factor-κB (NF-κB) in iPSC-NSC. Then, we evaluated the combination of PA-C delivery into the intrathecal space in a rat model of contusive SCI with stem cell transplantation. While we failed to observe significant improvements in locomotor function (BBB scale) in treated animals, histological analysis revealed that PA-C-treated or PA-C and iPSC-NSC + MSC-treated animals displayed significantly smaller scars, while PA-C and iPSC-NSC + MSC treatment induced the preservation of β-III Tubulin-positive axons. iPSC-NSC + MSC transplantation fostered the preservation of motoneurons and myelinated tracts, while PA-C treatment polarized microglia into an anti-inflammatory phenotype. Overall, the combination of stem cell transplantation and PA-C treatment confers higher neuroprotective effects compared to individual treatments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A hyaluronic acid demilune scaffold and polypyrrole-coated fibers carrying embedded human neural precursor cells and curcumin for surface capping of spinal cord injuries

  • Elkhenany, Hoda|||0000-0003-2638-8640
  • Bonilla, Pablo
  • Giraldo, Esther
  • Alastrue-Agudo, Ana|||0000-0002-9326-2119
  • Edel, Michael J.|||0000-0002-5619-8680
  • Vicent, María Jesús
  • Gisbert Roca, Fernando
  • Marínez Ramos, Cristina
  • Rodríguez Doblado, Laura
  • Monleón Pradas, Manuel
  • Moreno Manzano, Victoria
Tissue engineering, including cell transplantation and the application of biomaterials and bioactive molecules, represents a promising approach for regeneration following spinal cord injury (SCI). We designed a combinatorial tissue-engineered approach for the minimally invasive treatment of SCI-a hyaluronic acid (HA)-based scaffold containing polypyrrole-coated fibers (PPY) combined with the RAD16-I self-assembling peptide hydrogel (Corning® PuraMatrix™ peptide hydrogel (PM)), human induced neural progenitor cells (iNPCs), and a nanoconjugated form of curcumin (CURC). In vitro cultures demonstrated that PM preserves iNPC viability and the addition of CURC reduces apoptosis and enhances the outgrowth of Nestin-positive neurites from iNPCs, compared to non-embedded iNPCs. The treatment of spinal cord organotypic cultures also demonstrated that CURC enhances cell migration and prompts a neuron-like morphology of embedded iNPCs implanted over the tissue slices. Following sub-acute SCI by traumatic contusion in rats, the implantation of PM-embedded iNPCs and CURC with PPY fibers supported a significant increase in neuro-preservation (as measured by greater βIII-tubulin staining of neuronal fibers) and decrease in the injured area (as measured by the lack of GFAP staining). This combination therapy also restricted platelet-derived growth factor expression, indicating a reduction in fibrotic pericyte invasion. Overall, these findings support PM-embedded iNPCs with CURC placed within an HA demilune scaffold containing PPY fibers as a minimally invasive combination-based alternative to cell transplantation alone.